Skip to content

Prime Medicine PRME Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Operating margin-4,498.1%+2,289pp-6,787.4%
Net margin-4,342.4%+2,224pp-6,566.6%
Returns
Return on equity-146.8%-9.9pp-136.9%-48.7pp-88.2%
Efficiency
Asset turnover0.0×
Liquidity
Current ratio4.8×-0.7×5.6×+3.0×2.5×-8.6×11.1×+6.4×
Leverage
Debt-to-equity+0.7×0.3×+0.2×0.1×0.0×0.1×
Per Share
Book value per share$0.81-37.1%$1.29-11.7%$1.46-84.3%$9.33+177%
Valuation
Market capitalization$574.36M+111%$382.99M-55.6%$862.76M-37.4%$1.38B
Price / sales124×128.4×
Price / book7.5×+4.9×2.5×-4.0×6.5×+2.1×4.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Prime Medicine's ratios come from?
Every ratio is computed from Prime Medicine's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.